CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
Open Access
- 28 May 2019
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 19 (1) , 1-10
Abstract
Deletion of the CDKN2A locus is centrally involved in the development of several malignancies. In malignant pleural mesothelioma (MPM), it is one of the most frequently reported genomic alteration. MPM is strongly associated with a patients’ asbestos exposure. However, the status of CDKN2A and the expression of the corresponding protein, p16, in relation to MPM patient’s asbestos exposure is poorly known. Copy number alterations in 2p16, 9q33.1 and 19p13 have earlier been shown to accumulate in lung cancer in relation to asbestos exposure but their status in MPM is unclear. We studied DNA copy numbers for CDKN2A using fluorescence in situ hybridization (FISH) and p16 expression by immunohistochemistry (IHC) in 92 MPM patients, 75 of which with known asbestos exposure status. We also studied, in MPM, copy number alterations in 2p16, 9q33.1 and 19p13 by FISH. We were unable to detect an association between p16 expression and pulmonary asbestos fiber count in MPM tumor cells. However, significantly more MPM patients with high pulmonary asbestos fiber count (> 1 million fibers per gram [f/g]) had stromal p16 immunoreactivity than MPM of patients with low exposure (≤ 0.5 million f/g) (51.4% vs 16.7%; p = 0.035, Chi-Square). We found that an abnormal copy number of CDKN2A in MPM tumor cells associated with a high pulmonary asbestos fiber count (p = 0.044, Fisher’s Exact test, two-tailed). In contrast to our earlier findings in asbestos associated lung cancer, DNA copy number changes in 2p16, 9q33 and 19p13 were not frequent in MPM although single cases with variable copy numbers on those regions were seen. We found two instances where the gene locus CDKN2A or its corresponding protein expression, is associated with high asbestos exposure levels. This suggests that there may be biological differences between the mesotheliomas with high pulmonary asbestos fiber count and those with low fiber count.Keywords
Funding Information
- Terveyden Tutkimuksen Toimikunta (115372)
- K. Albin Johanssons Stiftelse
- Työsuojelurahasto (109003)
This publication has 50 references indexed in Scilit:
- New Insights into Understanding the Mechanisms, Pathogenesis, and Management of Malignant MesotheliomasThe American Journal of Pathology, 2013
- Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory PhenotypeJournal of Biological Chemistry, 2011
- Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate TumorigenesisPLOS ONE, 2011
- Syntenic Relationships between Genomic Profiles of Fiber-Induced Murine and Human Malignant MesotheliomaThe American Journal of Pathology, 2011
- FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesotheliomaJournal of Clinical Pathology, 2010
- DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposureBritish Journal of Cancer, 2009
- Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical OutcomeCancer Research, 2008
- Genomic events associated with progression of pleural malignant mesotheliomaInternational Journal of Cancer, 2008
- Asbestos Burden Predicts Survival in Pleural MesotheliomaEnvironmental Health Perspectives, 2008
- My approach to the diagnosis of mesothelial lesionsJournal of Clinical Pathology, 2006